29 related articles for article (PubMed ID: 3342737)
1. [Initial results of immunolymphoscintigraphy in the diagnosis of axillary lymph node involvement in breast cancer patients].
Pateisky N; Philipp K; Kubista E; Skodler WD; Burchell J
Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):681-4. PubMed ID: 3803863
[TBL] [Abstract][Full Text] [Related]
2. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer.
Tjandra JJ; Russell IS; Collins JP; Andrews JT; Lichtenstein M; Binns D; McKenzie IF
Cancer Res; 1989 Mar; 49(6):1600-8. PubMed ID: 2647290
[TBL] [Abstract][Full Text] [Related]
3. Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3.
Fig LM; Brown RS; von Moll L; Appelman HD; Stevens R; Harness J; August D; Sondak VK; Chang AE; Zasadny KR; Fisher SJ; Johnson JW; Wicha MS; Colcher D; Lichter AS; Wahl RL
Nucl Med Biol; 1998 Apr; 25(3):251-60. PubMed ID: 9620631
[TBL] [Abstract][Full Text] [Related]
4. [The value of breast lymphoscintigraphy in the definition of axillary staging in cancer of the breast].
Serin D; Vinot JM; Martin P; Reboul F; Robin M; Chevallier J
Bull Cancer; 1986; 73(3):299-304. PubMed ID: 3756366
[TBL] [Abstract][Full Text] [Related]
5. Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases.
Schatten C; Barrada M; Mandeville R; Enzelsberger H; Angelberger P; Czerwenka K; Kubista E; Pateisky N
Nucl Med Commun; 1994 Jun; 15(6):422-9. PubMed ID: 8078637
[TBL] [Abstract][Full Text] [Related]
6. [Immunolymphoscintigraphy. A new procedure for noninvasive lymph node staging illustrated by the example of breast cancer].
Pateisky N; Schatten C; Enzelsberger H; Czerwenka K; Burchell J; Mandeville R
Dtsch Med Wochenschr; 1988 Feb; 113(7):250-5. PubMed ID: 3342737
[TBL] [Abstract][Full Text] [Related]
7. Immunolymphoscintigraphy.
Keenan AM
Semin Nucl Med; 1989 Oct; 19(4):322-31. PubMed ID: 2678483
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph nodes in breast cancer.
Wastell C
Surg Annu; 1978; 10():123-33. PubMed ID: 345499
[No Abstract] [Full Text] [Related]
10. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
11. The axillary lymph nodes in breast cancer. Seven years on.
Steele RJ
J R Coll Surg Edinb; 1983 Sep; 28(5):282-91. PubMed ID: 6358482
[No Abstract] [Full Text] [Related]
12. Management of axillary disease.
Caudle AS; Cupp JA; Kuerer HM
Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
